Iambic Therapeutics

Description

Builds AI-driven drug discovery technologies and experimental platforms to design molecular candidates and generate biological data for therapeutic pipelines and partners.

Iambic Therapeutics is located in the San Diego ecosystem.

Related

• Genesis TherapeuticsBuilds molecular AI models and a design platform to optimize small-molecule drug discovery and create new medicines for partners and…
• Enveda BiosciencesBuilds a drug discovery platform that analyzes natural chemistry to help drug hunters find potential medicines from largely unexplored…
• Poseida Therapeutics (Roche)Develops cell therapy candidates and related platform technologies, with legacy programs in a biotechnology pipeline for medicines…
• Tempus AI ($TEM)AI-driven precision medicine over clinical and molecular data. Public via $TEM (NASDAQ). Chicago HQ.
• MetabolonProvides untargeted and targeted metabolomics, lipidomics, and biopharma services to measure metabolites and lipids in biological samples…
• Mirror Physics CorporationDevelop AI-driven drug discovery software, providing tools for conformer generation, docking preparation, virtual screening, ADMET…
• InceptiveBuilds foundation models for designing sequence-based medicines, generating experimental training data when needed and partnering with…
• Lila SciencesBuilds AI and autonomous lab systems that generate hypotheses, run experiments, and learn from data to support discovery in science-driven…
• Pfizer Gene Therapy Sanford ($PFE)Gene-therapy drug substance, drug product, and biotechnology manufacturing site supporting Pfizer's rare-disease pipeline. Sanford NC site.
• BigHat BiosciencesDesigns AI-guided antibody therapeutics using automated wet-lab data generation to help drug development teams optimize multiple biological…
• Recursion ($RXRX)Builds an automated AI drug discovery platform that maps disease biology from cell images and lab data to design potential medicines for…
• Recursion PharmaceuticalsSalt Lake City AI-driven drug discovery company using high-throughput cell imaging and machine learning to identify therapeutic candidates.